Albarico, Roselle E.

HRN: 02-63-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2026
CEFUROXIME 1.5GM (VIAL)
01/20/2026
01/21/2026
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS With Intra CS IUD Insertion
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines